Sosei Inks GPCR Strategic Collaboration with Google’s Verily

January 11, 2022
Sosei Group said on January 6 that it has hooked up with Verily Life Sciences, a subsidiary of Google’s parent company Alphabet, to forge a strategic research collaboration to discover drugs against G-protein-coupled receptor (GPCR) targets for immune-mediated diseases. Through...read more